Literature DB >> 11091524

Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations.

.   

Abstract

We report a case of bilateral breast carcinoma in a patient with a strong family history, including 4 cases of breast carcinoma, 1 case of prostate carcinoma (father), 1 case of hepatocellular carcinoma (mother), 2 cases of gastric carcinoma, 1 case of lung carcinoma, and 1 case of lingual carcinoma, in second degree relatives, together with analysis of germ line p53 mutations. The patient was a 51-year-old female who had undergone mastectomy 9 years previously for an invasive ductal carcinoma of the right breast. Lymph nodes were free of metastases and the tumor had negative estrogen receptor (ER) status. Bone and lung metastases developed 18 months after surgery, and had been well controlled with chemoendocrine therapy. She subsequently underwent a modified radical mastectomy for carcinoma in the contralateral breast. This was an invasive lobular carcinoma with negative lymph node metastasis, negative p53 immunoreaction, negative c-erbB-2 protein and positive ER status. In this breast-prostate carcinoma-type cancer family there was a high incidence of breast carcinoma; the father, who had prostate carcinoma, was possibly a carrier of a breast carcinoma susceptible gene. We have however detected to p53 germ line mutations in the lymphocytes DNA of the patient and her niece. The accumulation of cancers in this family line remains to be elucidated further using other genetic markers.

Entities:  

Year:  1994        PMID: 11091524     DOI: 10.1007/BF02967046

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  12 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Screening for germ line TP53 mutations in breast cancer patients.

Authors:  A L Børresen; T I Andersen; J Garber; N Barbier-Piraux; S Thorlacius; J Eyfjörd; L Ottestad; B Smith-Sørensen; E Hovig; D Malkin
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

3.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  Genetic heterogeneity of early-onset familial breast cancer.

Authors:  H Sobol; S Mazoyer; S A Narod; S A Smith; D M Black; P Kerbrat; B Jamot; E Solomon; B A Ponder; D Guerin
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

6.  Familial effects of prostate and other cancers on lifetime breast cancer risk.

Authors:  D E Anderson; M D Badzioch
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer.

Authors:  A Arason; R B Barkardóttir; V Egilsson
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

9.  A clinicopathological analysis of breast cancer in patients with a family history.

Authors:  T Fukutomi; Y Kobayashi; T Nanasawa; H Yamamoto; H Tsuda
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; Y Tanaka; T Hirota; S Tsugane; M Shiraishi; K Toyoshima; T Yamamoto; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.